Skip to content

Applying neuroimaging transcriptomic analysis to investigate pathological mechanisms of anhedonia in depression

Applying neuroimaging transcriptomic analysis to investigate pathological mechanisms of anhedonia in depression

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092637
Enrollment
Unknown
Registered
2024-11-20
Start date
2024-06-12
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

depression with anhedonia:None
depression without anhedonia :None
Healthy controls :None

Sponsors

Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patient group: 1. Age: 18-45 years; 2. Ethnicity: Han Chinese; 3. Right-handedness; 4. First-episode patients; 5. Education: At least primary school graduate Normal social functioning prior to illness: 6. Diagnostic criteria: Meets the criteria for major depressive disorder as outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); 7. Medication history: No prior use of antipsychotics, antidepressants, benzodiazepines, or other central nervous system-affecting drugs; or antidepressant therapy limited to less than 2 weeks with monotherapy; 8. Voluntary participation in the study, with signed informed consent. For the anhedonia subtype of depression: Must meet the DSM-5 criteria for "loss of interest or pleasure"; Snaith-Hamilton Pleasure Scale (SHAPS) score > 5. Control group: 1. Age: 18-45 years; 2. Ethnicity: Han Chinese;3. Right-handedness; 4. Education: At least primary school graduate; 5. Normal social functioning; 6. Voluntary participation in the study, with signed informed consent.

Exclusion criteria

Exclusion criteria: Patient group: 1. Individuals with organic brain diseases, neurological disorders, or severe endocrine or metabolic diseases; 2. History of traumatic brain injury with a history of coma; 3. Previous diagnosis of other mental disorders as outlined in the DSM-5; 4. Non-compliance during assessments or inability to complete assessments effectively; 5. Presence of fixed metal dentures, cardiac pacemakers, or implanted metal prostheses. Control group: 1. History of mental illnesses diagnosed according to the DSM-5; 2. History of traumatic brain injury with a history of coma; 3. Positive family history of mental illness spanning two generations; 4. History of medication treatment involving antipsychotics, antidepressants, or similar; 5. Presence of fixed metal dentures, cardiac pacemakers, or implanted metal prostheses.

Design outcomes

Primary

MeasureTime frame
SHAPS scores;

Secondary

MeasureTime frame
HAMD scores;

Countries

China

Contacts

Public ContactSugai Liang

Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine

sgl011@163.com+86 159 2842 1891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026